Neural Stem Cell Transplantation And Myelination: Results Of A Phase I Trial In Pelizaeus-Merzbacher Disease

被引：0
|
作者：
Gupta, Nalin
Henry, Roland
Strober, Jonathan
Kang, Sang-Mo
Lim, Daniel
Bucci, Monica
Caverzasi, Eduardo
Gaetano, Laura
Mandelli, Maria
Ryan, Tamara
Perry, Rachel
Farrell, Jody
Jeremy, Rita
Ulman, Mary
Huhn, Stephen
Barkovich, James
Rowitch, David
机构：
来源：
JOURNAL OF NEUROSURGERY | 2013年 / 119卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A566 / A566
页数：1
相关论文
共 50 条
  • [31] Results of a phase I clinical trial of allogeneic mesenchymal stem cell (MSC) transplantation in patients with Hurler disease and metachromatic leukodystrophy (MLD).
    Koç, ON
    Day, J
    Brown, D
    Andrews, P
    Peters, C
    Nieder, M
    Gerson, SL
    Lazarus, HM
    Caplan, AI
    Laughlin, MJ
    Raghavan, S
    Kolodny, EH
    Krivit, W
    BLOOD, 2000, 96 (11) : 170A - 170A
  • [32] Generation of Pelizaeus-Merzbacher disease (PMD) mutant (PLP1-C33Y) in induced pluripotent stem cell (iPSC) by CRISPR/Cas9 genome editing
    Schreiber, Marie-Kristin
    Zafeiriou, Maria-Patapia
    STEM CELL RESEARCH, 2024, 74
  • [33] Autologous hematopoietic stem cell transplantation for refractory Crohn's disease, the summary of phase I trial
    Oyawa, Y
    Craig, RM
    Quigley, K
    Statkute, L
    Burt, RK
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 90 - 90
  • [34] Three young adult patients with Pelizaeus-Merzbacher disease who showed only waves I and II in auditory brainstem responses but had good auditory perception
    Kaga, K
    Tamai, F
    Kodama, M
    Kodama, K
    ACTA OTO-LARYNGOLOGICA, 2005, 125 (09) : 1018 - 1023
  • [35] Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson’s Disease
    Ibon Garitaonandia
    Rodolfo Gonzalez
    Trudy Christiansen-Weber
    Tatiana Abramihina
    Maxim Poustovoitov
    Alexander Noskov
    Glenn Sherman
    Andrey Semechkin
    Evan Snyder
    Russell Kern
    Scientific Reports, 6
  • [36] Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson's Disease
    Garitaonandia, Ibon
    Gonzalez, Rodolfo
    Christiansen-Weber, Trudy
    Abramihina, Tatiana
    Poustovoitov, Maxim
    Noskov, Alexander
    Sherman, Glenn
    Semechkin, Andrey
    Snyder, Evan
    Kern, Russell
    SCIENTIFIC REPORTS, 2016, 6
  • [37] Phase I Clinical Trial Update: Human Neural Stem Cell Treatment for Parkinson's Disease
    Gonzalez, R.
    Garitaonandia, I.
    Sherman, G.
    Semechkin, A.
    Braine, E.
    Shahrul, A.
    Nair, G.
    Evans, A. H.
    Kern, R. A.
    CELL TRANSPLANTATION, 2019, 28 (04) : 469 - 469
  • [38] Generation of the human induced pluripotent stem cell line (ZJUi005-A) from a patient with Pelizaeus-Merzbacher disease (PMD) carrying a novel hemizygous mutation in PLP1 gene
    Liu, Bei
    Chen, Lang
    Sun, Jian
    Zhang, Li
    Chen, Min
    Qian, Yeqing
    Wang, Yanlin
    Yan, Kai
    Hou, Linxiao
    Huang, Yingzhi
    Zhang, Dan
    Xu, Yuming
    Yu, Jialing
    Zhang, Jin
    Dong, Minyue
    STEM CELL RESEARCH, 2020, 45
  • [39] Multiplex ligation-dependent probe amplification for rapid detection of proteolipid protein I gene duplications and deletions in affected males and carrier females with Pelizaeus-Merzbacher disease
    Warshawsky, Ilka
    Chernova, Olga B.
    Huebner, Christian A.
    Stindl, Reinhard
    Henneke, Marco
    Gal, Andreas
    Natowicz, Marvin R.
    CLINICAL CHEMISTRY, 2006, 52 (07) : 1267 - 1275
  • [40] Autologous hematopoietic stem cell transplantation for refractory Crohn's disease, the summary of phase I trial.
    Oyama, Y
    Craig, R
    Traynor, A
    Statkute, L
    Burt, R
    BLOOD, 2005, 106 (11) : 819A - 819A
12345